- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Glabellar Crease
Total 10000 results
-
UNICANCERNational Cancer Institute, FranceActive, not recruiting
-
Istanbul Medipol University HospitalThe Scientific and Technological Research Council of TurkeyEnrolling by invitationHealth Behavior | Breast Cancer Female | SurvivorshipTurkey
-
Roswell Park Cancer InstituteCompletedInvasive Breast CarcinomaUnited States
-
University of AarhusCompletedBreast Cancer Female | Decision Making | Mammography Screening | Information Seeking BehaviorDenmark
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Bayer; United States Department of Defense; Canadian...TerminatedNode Positive HER2 Negative Breast CancerUnited States, Canada, Puerto Rico, Guam
-
Qingdao Central HospitalCompletedHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastChina
-
Ataturk UniversityCompleted
-
Isfahan University of Medical SciencesCompletedBreast Cancer SurvivorsIran, Islamic Republic of
-
Aultman Health FoundationTerminatedMetastatic Breast Cancer | Thyroid DysfunctionUnited States
-
University of MinhoFoundation for Science and Technology, PortugalCompletedBreast Cancer FemalePortugal
-
ITAB - Institute for Advanced Biomedical TechnologiesCompleted
-
Vanderbilt-Ingram Cancer CenterTerminatedEndocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast CancerHormone-sensitive Metastatic Breast CancerUnited States
-
Mayo ClinicNot yet recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Locally Advanced Hormone Receptor-Positive Breast CarcinomaUnited States
-
Martina LojovaRecruiting
-
Guangdong Provincial People's HospitalNot yet recruitingNeoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Taiho Oncology, Inc.TerminatedMetastatic Breast Cancer | FGFR2 Amplification | FGFR 1 High AmplificationItaly, United States, France, United Kingdom, Spain, Portugal, Canada
-
Firat UniversityCompletedBreast Cancer Patients Receiving ChemotherapyTurkey
-
Beth Israel Deaconess Medical CenterNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Dana-Farber Cancer...CompletedBreast Cancer | Aromatase Inhibitors | ER+ Breast CancerUnited States
-
University of California, IrvineEli Lilly and CompanyTerminatedBreast Neoplasm | Hormone Receptor Positive Breast CarcinomaUnited States
-
Angle plcCompletedHealthy Volunteers | Breast Cancer, MetastaticUnited States
-
Beijing Biostar Pharmaceuticals Co., Ltd.Chengdu Biostar PharmaceuticalsCompletedPK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast CancerAdvanced and Metastatic Breast CancerChina
-
Massachusetts General HospitalKully Family FoundationCompletedBreast Cancer | Breast Cancer Recurrent | Fasting | SurvivorshipUnited States
-
National Defense Medical Center, TaiwanChang Gung Memorial HospitalCompletedBreast Cancer | Mastectomy | Women | Breast-Conserving SurgeryTaiwan
-
Poitiers University HospitalActive, not recruitingSurgery | Female Breast Cancer | 75 Years Old and MoreFrance
-
Sunnybrook Health Sciences CentreGenomic Health®, Inc.CompletedHormone Receptor Positive Malignant Neoplasm of BreastCanada
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySun Yat-sen University; First People's Hospital of FoshanUnknownAdvanced Breast Cancer | Surgery | Breast Neoplasm FemaleChina
-
Samsung Medical CenterActive, not recruitingHER2-positive Breast Cancer | Chemotherapy Effect | Circulating Tumor DNAKorea, Republic of
-
Duke UniversityNational Center for Complementary and Integrative Health (NCCIH)CompletedAdvanced Breast Cancer Stage IVUnited States
-
Centro Hospitalar Lisboa OcidentalUnknownBreast Cancer Female | Hormone Dependent NeoplasmsPortugal
-
Michael O'ConnorGE HealthcareCompleted
-
AstraZenecaCompletedBreast Cancer Nos Metastatic RecurrentRomania
-
Radionetics OncologyRecruitingLocoregionally Recurrent Hormone-receptor Positive Breast Cancer | Metastatic Hormone Receptor Positive Breast CancerUnited States, Australia
-
Peter MacCallum Cancer Centre, AustraliaMonash Medical Centre; Monash HealthNot yet recruitingMetastatic Breast Cancer | Breast Cancer, Metastatic
-
Ain Shams UniversityRecruitingBreast Cancer Early Stage Breast Cancer (Stage 1-3)Egypt
-
Medical University of ViennaDaiichi SankyoRecruiting
-
Spexis AGTerminatedMetastatic Breast Cancer | Locally Recurrent Breast CancerSpain, Belgium, United States, United Kingdom, Korea, Republic of, Taiwan, Italy, Russian Federation, Czechia, France, Brazil, Argentina, Ukraine
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedInflammatory Breast CarcinomaUnited States
-
Asan Medical CenterCompletedStage IV Breast Cancer | Recurrent Breast CancerKorea, Republic of
-
Ontario Clinical Oncology Group (OCOG)Canadian Breast Cancer Research Alliance; Ontario Cancer Research NetworkCompletedMetastatic Breast Cancer | Recurrent Breast CancerCanada
-
University of Michigan Rogel Cancer CenterBreast Cancer Research FoundationTerminatedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Breast Ductal Carcinoma In Situ | Localized Breast CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | HER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
Kahramanmaras Sutcu Imam UniversityCompletedTriple Negative Breast Cancer | Carbonic Anhydrase IXTurkey
-
Leiden University Medical CenterThe Netherlands Cancer Institute; Borstkanker Onderzoek Groep; Comprehensive... and other collaboratorsSuspendedHER2-negative Breast Cancer | Hormone Receptor-positive Breast Cancer | Neoadjuvant Chemotherapy | Fasting Mimicking Diet | Pathological Complete Response | Objective Response RateNetherlands
-
University of Roma La SapienzaCompletedStage I Breast Cancer | Cancer, Treatment-Related | Systemic Inflammatory Response | Tumor of BreastItaly
-
Consorzio OncotechClinical Research Technology S.r.l.UnknownBreast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Locally Advanced Malignant NeoplasmItaly
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Recruiting
-
Shanghai JMT-Bio Inc.RecruitingEarly or Locally Advanced HER2-positive Breast CancerChina
-
Fudan UniversityNot yet recruiting
-
Mersin UniversityNot yet recruitingPatients With Breast CancerTurkey